GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Net Issuance of Preferred Stock

Invitro International (Invitro International) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Jun. 2097)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Invitro International's net issuance of preferred for the three months ended in Jun. 2097 was $0.00 Mil. The number is 0, which means that Invitro International has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Invitro International's net issuance of preferred for the trailing twelve months (TTM) ended in Jun. 2097 was $0.00 Mil.

Invitro International Net Issuance of Preferred Stock Historical Data

The historical data trend for Invitro International's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International Net Issuance of Preferred Stock Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
Net Issuance of Preferred Stock
Get a 7-Day Free Trial - - - - -

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Invitro International Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jun. 2097 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invitro International Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Invitro International's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Invitro International (Invitro International) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Net Issuance of Preferred Stock
Comparable Companies
ASX:LSH IDTA TSXV:TELO ASX:CTE XSAT:ALPH BOM:526301 ABMC BOM:541299 BOM:526546 NGM:LIFE B XLRM TSXV:AVCR TEAR WAR:BMX XKRX:271850 TSXV:MBI.H WAR:IGN BOM:526504 BOM:516110 SGX:505
Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Website
https://www.invitrointl.com
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.